Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on "Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185".
Not reported in abstract.
Where it sits
this study against the rest of the bpc-157 corpusSummary and findings
Not reported in abstract.
Abstract
We wish to thank the Authors of the comment for their interest in our manuscript [...].
Background
This paper addresses the biological mechanisms of BPC-157, particularly its effects on angiogenesis and nitric oxide. Previous studies have suggested various protective functions of BPC-157, but the clinical significance and applicability remain unclear. This commentary aims to synthesize existing literature and highlight potential medical applications of the peptide.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Without specific results or numeric findings, it is difficult to compare this commentary to prior literature or assess the clinical relevance of BPC-157. The lack of detailed outcomes limits the ability to draw meaningful conclusions regarding its effectiveness or safety.
Key findings
- Not reported in abstract.
Limitations
- Not reported in abstract.